35
Participants
Start Date
February 29, 2000
Primary Completion Date
October 31, 2002
Study Completion Date
August 31, 2003
FOLFOX regimen
fluorouracil
leucovorin calcium
oxaliplatin
Cancer Centers of the Carolinas, Greenville
Central Baptist Hospital, Lexington
Grant/Riverside Methodist Hospitals, Columbus
Cleveland Clinic Taussig Cancer Center, Cleveland
Michiana Hematology/Oncology P.C., South Bend
Lakeland Medical Center - St. Joseph, Saint Joseph
Lutheran General Cancer Care Center, Park Ridge
Loyola University Medical Center, Maywood
Evanston Northwestern Health Care, Evanston
Ingalls Memorial Hospital, Harvey
Columbia LaGrange Memorial Hospital, LaGrange
University of Illinois at Chicago, Chicago
Louis A. Weiss Memorial Hospital, Chicago
Oncology/Hematology Associates of Central Illinois, P.C., Peoria
Cancer Care Specialists of Central Illinois, S.C., Decatur
Central Illinois Hematology Oncology Center, Springfield
Yale Comprehensive Cancer Center, New Haven
University of Chicago Cancer Research Center, Chicago
Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
University of Michigan Comprehensive Cancer Center, Ann Arbor
Roswell Park Cancer Institute, Buffalo
University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan
National Cancer Institute (NCI)
NIH
University of Chicago
OTHER